Shoulder Innovations, Inc. · NYSE:SI
Shoulder Innovations — Q2 2026 Earnings Presentation
29 slides from Shoulder Innovations's earnings presentation, Aug 6, 2026
Slide 1: Investor Presentation
Investor Presentation May 2026 1
Slide 2: Forward Looking Statement
Forward Looking Statement Certain statements in this presentation and the accompanying oral commentary are forward-looking statements and relate to or are based on estimates regarding market and industry data that Shoulder Innovations, Inc. (the "Company") prepared based on management's knowledge an
Slide 3: Leader in Shoulder Surgical Care
Leader in Shoulder Surgical Care 1 Transforming the $2.8B global annual shoulder $47.3M arthroplasty market1 2025 Net Revenue Purpose-built, disruptive ecosystem to address existing 2 limitations within shoulder arthroplasty Pioneer of the InSet Glenoid, a biomechanically designed ~57% 3 implant to
Slide 4: Experienced Leadership Team Redefining Shoulder Surgical Care
Experienced Leadership Team Redefining Shoulder Surgical Care Rob Ball Matt Ahearn Dave Blue Jon Osborne Jeff Points CEO COO Chief Customer Experience VP, Commercial Development CFO Officer Proven History of Successful Shoulder Innovation and Commercialization Global Shoulder Simpliciti Simpliciti F
Slide 5: Shoulder Pain is Highly Prevalent with Quality-of-Life-Reducing Impacts
Shoulder Pain is Highly Prevalent with Quality-of-Life-Reducing Impacts Key Drivers of Shoulder Pain Shoulder Pain is Widespread Osteoarthritis 1 in 5 People 8+ Million over 65 suffer from annual physician visits Rheumatoid Arthritis shoulder pain in the U.S. related to shoulder conditions in the U.
Slide 6: Shoulder Arthroplasty: Initial Focus Within Shoulder Surgical Care Market
Shoulder Arthroplasty: Initial Focus Within Shoulder Surgical Care Market Established Surgical Procedures for Reducing Joint Pain and Restoring Shoulder Motion Osteoarthritis Osteoarthritis + Rotator Cuff Deficiency Anatomic Total Shoulder Arthroplasty (aTSA) Reverse Total Shoulder Arthroplasty (rTS
Slide 7: Shoulder Arthroplasty is One of the Fastest Growing Segments in MedTech
Shoulder Arthroplasty is One of the Fastest Growing Segments in MedTech Large & Growing TAM ASC Will Capture Future Growth Forward Market Growth Rate (%) Total Joint Arthroplasty Example3 $2.8B (MM) 2.0 >10% 2 Global Annual Market1 1.5 OUS Market 6 51% ~7% ~ $1.0B 7 ~5% 1.0 15% 7 7 ~4% ~4% U.S.Shoul
Slide 8: Current Solutions in the Market Have Significant Limitations
Current Solutions in the Market Have Significant Limitations ~40% of Implants Subject to 1 Low Rates of Implant Survivorship Revision Surgery1 ~15% of Subscapularis Tendons 2 Frequent Post-Operative Complications Fail Following an aTSA Procedure2 Positioning as Little as 5 Degrees 3 Imprecise Implan
Slide 9: Highly Differentiated Ecosystem Across Shoulder Surgical Care
We Have Developed a Highly Differentiated Ecosystem that Seeks to Improve Core Components of Shoulder Surgical Care ProVoyance AI and ML-enabled 3D aTSA and rTSA systems Advanced leveraging our InSet glenoid Technology bespoke surgical plans Implant Systems Enabling aTSA and rTSA procedures with two
Slide 10: Traditional Implant Designs Have Low Rates of Implant Survivorship
1 Traditional Implant Designs Have Low Rates of Implant Survivorship and Often Require Additional Surgical Intervention With traditional implants, normal movement can rock the glenoid loose Example of Traditional Glenoid Implant 01 Too much loosening can cause pain, and necessitate subsequent revisi
Slide 11: Novel InSet Glenoid Design Sets a New Standard
Our Novel InSet Glenoid Design Sets a New Standard for Fixation and Stability Traditional Implant, Sitting on InSet Glenoid Top of Bony Surface Implant on top of the bone InSet Glenoid, Sitting Within a Rim of Bone Complex articular Peripheral bone ledge is surface further reduces buttress against r
Slide 12: InSet Glenoid Technology Supported by Data
InSet Glenoid Technology Supported by Data that Demonstrate Significant Clinical Benefits and Improved Patient Outcomes Key Clinical Factors InSet's Differentiation Pre-Operation Rotation Forward Flexion 87% Reduction2 In “Rocking Horse” Motion In constant pain and unable to Pain-free and enjoying
Slide 13: Common Post-Operative aTSA Complications Require Surgical Conversion to rTSA
Common Post-Operative aTSA Complications Require Surgical 2 Conversion to rTSA However, Traditional Implants are Not Designed for Replacement, Revision, or rTSA-Conversion Procedures Traditional Implants…. Post-Operative Complications Can Include… Overstuffing, shoulder dislocation, humeral fracture
Slide 14: InSet Glenoid Technology Across a Full Range of Solutions
InSet Glenoid Technology Leveraged Across a Full Range of Solutions for Both aTSA and rTSA Procedures InSet aTSA System InSet rTSA System 14
Slide 15: Post-Operative aTSA Complications Driving Higher rTSA Volumes
Frequency of Post-Operative aTSA Gradual Market Transition Towards Complications are Driving Significantly Inlay Reverse Arthroplasty Higher rTSA Volumes Evolution of Shoulder Arthroplasty Procedure Mix Onlay 100% Arthroplasty 80% 60% Reverse now 70%+ of procedures 40% Inlay 20% Arthroplasty 0% Tota
Slide 16: InSet Reverse Stem Provides Biomechanical Advantages
InSet Reverse Stem Provides Biomechanical Advantages Engineered to Provide Bone Sparing Implant Options to Achieve Desirable Range of Motion Biomechanics Biomechanical advantage: a more 41%1 “anatomic” reverse shoulder Traditional construct of rTSAs Have Limited Reverse Internal Rotation after Surge
Slide 17: InSet Stems Are Compatible Across Implant Systems
Our InSet Stems Are Compatible Across a Full Range of Implant Systems, Enabling Seamless Interchangeability Between aTSA and rTSA All InSet Stems are Compatible with Both …Making Revision / Conversion Surgeries Three InSet Stem Options aTSA & rTSA Humeral Heads… Straightforward Stemless aTSA InSet H
Slide 18: Limited Surgical Planning Can Lead to Imprecise Implant Positioning
3 Limited Surgical Planning Can Lead to Imprecise Implant Positioning Implant Positioning as Little as 5 Degrees Off Angle Can Lead to Inferior Patient Outcomes Surgeons have historically relied on basic imagery to inform surgical approach Lacks 3D bone rendering No biomechanical simulation Shoulder
Slide 19: ProVoyance 3D Platform Streamlines Pre-Operative Planning
Our ProVoyance 3D Platform Streamlines Pre-Operative Planning Process • Hands-on procedural planning performed by surgeons at the site of care • Integrates AI/ML to transform CT images into 3D renderings of patient-specific anatomy • Provides enhanced preoperative planning experience for surgeons •
Slide 20: Market Shifts Towards ASC Setting Present Compelling Dynamic
4 Market Shifts Towards ASC Setting Present Compelling Dynamic Transition to thetoOutpatient Continued Transition the OutpatientSetting Setting ASCs as Site of Care Present Numerous Advantages Surgery is Experiencing a Long-Term Secular Shift Toward ASC Inpatient Outpatient ✓ ASC has emerged as a co
Slide 21: Capital Efficient Technology Suite Reduces Complexity and Cost
Our Capital Efficient Technology Suite Reduces Complexity & Cost Status Quo Significant Reduction Up to 9 surgery trays to complete a single procedure in Surgery Tray Usage ✓ Full SI product portfolio and all procedures supported by two instrument trays ✓ Fewer SKUs and trays reduce the implant foot
Slide 22: Consistent Innovation with Robust Pipeline of New Technologies
Consistent Innovation with Robust Pipeline of New Technologies 2016 – 2023 Pipeline I-Series Expansion and New Indications • Fully launched I-70 in September 2025, expanding I-Series product line • Fully launched I-135 in 2026 for primary, revision, and fracture indications of the humera
Slide 23: Strategic Partnership with INS for Micro-Robotic Platform
Strategic Partnership with INS to Introduce a Micro-Robotic Platform for Shoulder Arthroplasty ✓ Integrates directly with ProVoyance Platform, creating seamless enabling technology experience from preoperative planning throughout intraoperative execution ✓ New economic model for surgical robotics –
Slide 24: Integrated Commercial Approach Accelerates Adoption
Integrated Commercial Approach Accelerates Adoption, Drives Deeper Surgeon Relationships, and Enhances Long-Term Retention Commercial Leadership: CEME: Distributor Management, Target Prospecting, ip C rsh Me ust Key Account Conversions, Utilization Forecasting, Performance Management e dic o ad al M
Slide 25: Financial Summary Q1 2026 Highlights
Financial Summary Q1 2026 Highlights Trailing Twelve Months Revenue ($ in USD millions) • Revenue of $16.7M, 65% Y/Y 54% $53.9 CAGR1 • 2,184 total implant systems sold, 51% Y/Y $47.3 • Continued rapid increase in new surgeons $41.6 $37.3 • Gross margin of 77.7%, +80bps Y/Y $34.6 • $108.5M in cash, c
Slide 26: Multiple Drivers to Sustain Above-Market Growth
Multiple Drivers to Sustain Above-Market Growth Entry into Sports Medicine and Trauma Long-Term Above Entry into select Market Growth international ~$7.7K Current ASP4 markets New Indications will have higher ASPs Revision, Fracture, Metal Sensitivity Near-Term Above indications Market Growth ~1,800
Slide 27: Multiple Initiatives to Drive Profitability
Multiple Initiatives to Drive Profitability Attractive Gross Margin Profile Key Profitability Initiatives 79% Manufacturing and 77% 77% ASP Supply Chain Cost- Down Initiatives R&D and SG&A Spend Salesforce Productivity Moderating as a Function of Revenue Modest Capex Improving Working Investments Ca
Slide 28: Investment Highlights
Investment Highlights Disruptive ecosystem to address existing limitations within $2.8Bn annual global shoulder arthroplasty market Strong clinical results and positive outcomes for patients and surgeons Well-positioned as shoulder surgical care market grows in outpatient settings Unique commercial
Slide 29: Thank You
SHOULDER INNOVATIONS Thank You